Charles Rosier - | CrunchBase

Charles Rosier - | CrunchBase

The Career of Charles Rosier

BTG Pactual has been respected in international markets for more than 30 years and has 2,500 employees throughout Latin America. Charles Rosier (Crunchbase) managed the French-speaking markets of France, Belgium, as well as Quebec. He is known as a great investment banker who has 15 years of experience in that market.

Charles Rosier supported Luci MPOWERD, a clean and renewable power solution-provider. The company was able to create innovative solutions because of the support he gave. Economical LED lanterns were developed by MPOWERD to provide cost-effective energy solutions to poor countries. MPOWERD was financed by Charles Rosier to develop lanterns and other energy solutions. With this, MPOWERD successfully delivered these effective solutions to more than 25 poor nations around the world.

Charles Rosier and His Work Experiences

BTG Pactual is an investment bank located in Latin America, with whom Charles Rosier was a partner for years. GMS or Goldman Sachs is one of the best-known investment banks in the world. In his position as their Managing Director, he paid much mind to public asset management. Five principles (Client Focus, Long Term View, Global Thinking Presence, Meritocracy and Partnership and World-Class Governance) were put in place by Charles Rosier during his stay at BTG Pactual.

How Charles Rosier Was Educated

Charles Rosier join UBS Warburg Investment Bank after being a part of Lehman Brothers in 1996. He received his degree from ESCP Europe, which opened the path to his initial profession. Gaining his scientific Baccalaureate degree (equivalent to A-levels in the UK), Charles Rosier was able to attend to further education.

Charles Rosier: Successful Healthcare Projects

The drug project Charles Rosier funded was for the treatment of stroke known to cause spinal cord problems. The investment by him allowed them to do studies and, because of that, he was given a specific profit-share. Baulieu and his colleagues found it difficult to develop a new drug due to lack of budget, which he addressed. With his eagerness to contribute to the healthcare industry, Charles Rosier invested in the Mapreg Drug Project.